Men prescribed testosterone replacement therapy to restore their male sex hormones to normal levels should not be afraid that the treatment will raise their risk of prostate cancer.
In fact, the researchers found not only that men prescribed testosterone replacement therapy (TRT) for longer than a year showed no overall increase in risk of developing prostate cancer, but that if anything, their risk for aggressive disease was 50 percent lower than equivalent men not prescribed TRT.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
